XML 42 R32.htm IDEA: XBRL DOCUMENT
v3.22.2.2

Basis of Presentation, Summary of Significant Accounting Policies and Change in Accounting Principles (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2022
Accounting Policies [Abstract] |
Schedule of Restricted Cash And Cash Equivalents | Restricted cash and restricted investments include cash and investments used to collateralize various contractual obligations (in thousands) as follows:
| September 30, 2022 |  | December 31, 2021
Collateral for letters of credit for facility leases (1) | $ | 2,269 |  |  | $ | 3,769 |
Collateral with financial institutions (2) | 10,873 |  |  | 11,662 |
Claims processing services (3) | 24,904 |  |  | 73,226 |
Other | 16 |  |  | 5 |
Total restricted cash and restricted investments | $ | 38,062 |  |  | $ | 88,662 |
Current restricted cash | 25,057 |  |  | 75,685 |
Total current restricted cash and restricted investments | $ | 25,057 |  |  | $ | 75,685 |
Non-current restricted cash | 13,005 |  |  | 12,977 |
Total non-current restricted cash and restricted investments | $ | 13,005 |  |  | $ | 12,977 |
———————— (1)Represents restricted cash related to collateral for letters of credit required in conjunction with lease agreements. See Note 12 for further discussion of our lease commitments. (2)Represents collateral held with financial institutions for risk-sharing and other arrangements which are held in a FDIC participating bank account. See Note 17 for discussion of fair value measurement and Note 11 for discussion of our risk-sharing arrangements. (3)Represents cash held by the Company related to claims processing services on behalf of partners. These are pass-through amounts and can fluctuate materially from period to period depending on the timing of when the claims are processed. The following table provides a reconciliation of cash and cash equivalents and restricted cash reported within the consolidated balance sheets that sum to the total of the same amounts shown in the consolidated statements of cash flows (in thousands):
| September 30,
| 2022 |  | 2021
Cash and cash equivalents | $ | 156,756 |  |  | $ | 252,496 |
Restricted cash and restricted investments | 38,062 |  |  | 29,259 |
Total cash and cash equivalents and restricted cash shown in the consolidated statements of cash flows (1) | $ | 194,818 |  |  | $ | 281,755 |
———————— (1)As a result of the closing of the sale of True Health during the first quarter of 2021, the consolidated statement of operations and related financial information reflect the Company’s operations and assets and liabilities of True Health as discontinued operations. Cash flows and comprehensive income have not been adjusted and are included in the consolidated statements of cash flows and consolidated statements of comprehensive income (loss) for the nine months ended September 30, 2021. See Note 5.
Schedule of Cash And Cash Equivalents | The following table provides a reconciliation of cash and cash equivalents and restricted cash reported within the consolidated balance sheets that sum to the total of the same amounts shown in the consolidated statements of cash flows (in thousands):
| September 30,
| 2022 |  | 2021
Cash and cash equivalents | $ | 156,756 |  |  | $ | 252,496 |
Restricted cash and restricted investments | 38,062 |  |  | 29,259 |
Total cash and cash equivalents and restricted cash shown in the consolidated statements of cash flows (1) | $ | 194,818 |  |  | $ | 281,755 |
———————— (1)As a result of the closing of the sale of True Health during the first quarter of 2021, the consolidated statement of operations and related financial information reflect the Company’s operations and assets and liabilities of True Health as discontinued operations. Cash flows and comprehensive income have not been adjusted and are included in the consolidated statements of cash flows and consolidated statements of comprehensive income (loss) for the nine months ended September 30, 2021. See Note 5.
Schedule of Intangible Assets | The following summarizes the estimated useful lives by asset classification:
Corporate trade name | 10 - 20 years
Customer relationships | 10 - 25 years
Technology | 5 years
Provider network contracts | 3 - 5 years
Details of our intangible assets (in thousands, except weighted-average useful lives) as of September 30, 2022 and December 31, 2021 are presented below:
| September 30, 2022 |  | December 31, 2021
| Weighted- Average Remaining Useful Life |  | Gross Carrying Amount |  | Accumulated Amortization |  | Net Carrying Value |  | Weighted- Average Remaining Useful Life |  | Gross Carrying Amount |  | Accumulated Amortization |  | Net Carrying Value
Corporate trade name | 13.0 |  | $ | 43,600 |  |  | $ | 9,847 |  |  | $ | 33,753 |  |  | 12.4 |  | $ | 25,800 |  |  | $ | 7,693 |  |  | $ | 18,107 |
Customer relationships | 16.0 |  | 465,019 |  |  | 86,623 |  |  | 378,396 |  |  | 14.9 |  | 311,019 |  |  | 72,697 |  |  | 238,322 |
Technology | 2.9 |  | 111,822 |  |  | 78,648 |  |  | 33,174 |  |  | 2.0 |  | 87,922 |  |  | 73,378 |  |  | 14,544 |
Below market lease, net | 0.6 |  | 1,218 |  |  | 1,100 |  |  | 118 |  |  | 1.3 |  | 1,218 |  |  | 950 |  |  | 268 |
Provider network contracts (1) | 1.5 |  | 16,553 |  |  | 10,596 |  |  | 5,957 |  |  | 2.2 |  | 16,417 |  |  | 7,874 |  |  | 8,543 |
Total intangible assets, net |  |  | $ | 638,212 |  |  | $ | 186,814 |  |  | $ | 451,398 |  |  |  |  | $ | 442,376 |  |  | $ | 162,592 |  |  | $ | 279,784 |

X
- References No definition available. + Details
Name: | us-gaap_AccountingPoliciesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the components of cash and cash equivalents. + References No definition available. + Details
Name: | us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 2 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 1 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275 + Details
Name: | us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of cash and cash equivalents restricted as to withdrawal or usage. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-03(1)(a)) -URI https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 8 -URI https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-03(a)(2)) -URI https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910 + Details
Name: | us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration